This document summarizes guidelines from the 2017 ACC/AHA/HFSA Focused Update for the management of heart failure. It discusses the initial evaluation of heart failure patients including the use of biomarkers for prevention, diagnosis and prognosis. It also reviews pharmacological treatments for stage C heart failure with reduced or preserved ejection fraction. Additionally, it examines important comorbidities seen in heart failure patients such as anemia, hypertension, and sleep disordered breathing.

1. 2017 ACC/AHA/HFSA FOCUSED UPDATE
OF THE 2013 ACCF/AHA
GUIDELINE FOR THE MANAGEMENT OF
HEART FAILURE
Prepared by Dr/Abdel Rahman Essam
Msc in Internal Medicine
2017 ACC/AHA/HFSA FOCUSED UPDATE
OF THE 2013 ACCF/AHA
GUIDELINE FOR THE MANAGEMENT OF
HEART FAILURE

5. INITIAL AND SERIAL EVALUATION OF
THE HF PATIENT

6. BIOMARKERS

7. BIOMARKERS

8. BIOMARKERS

9. BIOMARKERS

10. BIOMARKERS FOR PREVENTION

11. BIOMARKERS FOR DIAGNOSIS

12. BIOMARKERS FOR PROGNOSIS

14. BIOMARKERS

15. PHARMACOLOGICAL TREATMENT

17. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

18. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

19. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

20. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

21. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

22. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

23. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

24. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH REDUCED EJECTION FRACTION:

25. PHARMACOLOGICAL TREATMENT FOR STAGE C HF WITH
REDUCED EJECTION FRACTION:

30. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH PRESERVED EJECTION FRACTION:

31. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH PRESERVED EJECTION FRACTION:

32. PHARMACOLOGICAL TREATMENT FOR STAGE C HF
WITH PRESERVED EJECTION FRACTION:

33. IMPORTANT COMORBIDITIES IN HF

34. COMORBIDITIES IN HF:ANEMIA

35. COMORBIDITIES IN HF:ANEMIA

36. COMORBIDITIES IN HF:ANEMIA

37. COMORBIDITIES IN HF: HYPERTENSION

38. COMORBIDITIES IN HF: HYPERTENSION

39. COMORBIDITIES IN HF: HYPERTENSION

40. COMORBIDITIES IN HF: SLEEP DISORDERED BREATHING

41. COMORBIDITIES IN HF: SLEEP DISORDERED BREATHING

42. THANK YOU